Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Jun 28;2(5):388-390.
doi: 10.1016/j.hrcr.2016.05.001. eCollection 2016 Sep.

'Runaway' vagal nerve stimulator: a case of cyclic asystole

G Sofia Tomova  1 , Duc H Do  1 , Yuliya Krokhaleva  1 , Henry Honda  1 , Eric Buch  1 , Noel G Boyle  1
Affiliations
Case Reports

'Runaway' vagal nerve stimulator: a case of cyclic asystole

G Sofia Tomova et al. HeartRhythm Case Rep. .
No abstract available

Keywords: Asystole; Device malfunction; Epilepsy; Vagal nerve stimulator; Ventricular tachycardia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A representative episode of asystole lasting 13 seconds, which was due to high-degree atrioventricular block following electrical cardioversion over the patient’s vagal nerve stimulator.
Figure 2
Figure 2
A posterioanterior chest radiograph that was obtained following the implantation of a dual-chamber implantable cardioverter-defibrillator in the right chest. The vagal nerve stimulator is seen in the left subpectoral area with a thin lead (red arrows) traversing up to the left vagal nerve in the neck to which is it is attached.
Figure 3
Figure 3
A programming wand for the Cyberonics vagal nerve stimulator. This tool connects to a tablet computer and is placed over the vagal nerve stimulator to interrogate and program device settings.
See this image and copyright information in PMC

References

    1. VNS therapy systems physician’s manual for healthcare professionals. Cyberonics [LivaNova], 2015. 〈www.VNStherapy.com〉.
    1. Packer M., Bristow M.R., Cohn J.N., Colucci W.S., Fowler M.B., Gilbert E.M., Shusterman N.H. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334(21):1349–1355. - PubMed
    1. Swedberg K., Komajda M., Bohm M., Borer J.S., Ford I., Dubost-Brama A., Lerebours G., Tavazzi L. SHIFT Investigators. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomized placebo-controlled study. Lancet. 2010;376(9744):875–885. - PubMed
    1. Zannad F., De Ferrari G.M., Tuinenburg A.E. Chronic vagal stimulation for the therapy of low ejection fraction heart failure: results of the neural cardiac therapy for heart failure (NECTAR-HF) randomized controlled trial. Euro Heart J. 2015;36(7):425–433. - PMC - PubMed
    1. Hauptman P., Schwartz P., Gold M., Borggrefe M., Van Veldhuisen D., Starling R., Mann D.-H.F. Am Heart J. 2012;163(6):954–962. - PubMed

Publication types

LinkOut - more resources